VNDA
What one share of Vanda Pharmaceuticals holds
Pharmaceutical Preparations
Vanda Pharmaceuticals Inc. (we, our, the Company or Vanda) is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.
Vanda Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.63 |
|---|---|
| Profit | −$4.62 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$2.40 |
| Cash and investments | $0.92 |
| Book value | $3.64 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $3.36 | −$0.41 | $0.03 | −$0.22 | — | $2.98 |
| 2017 | $3.69 | −$0.35 | $0.04 | −$0.08 | — | $2.92 |
| 2018 | $3.64 | $0.48 | $0.01 | $0.56 | — | $5.25 |
| 2019 | $4.14 | $2.11 | $0.02 | $0.82 | — | $7.67 |
| 2020 | $4.50 | $0.42 | $0.03 | $0.91 | — | $8.26 |
| 2021 | $4.72 | $0.58 | $0.01 | $1.12 | — | $9.03 |
| 2022 | $4.46 | $0.11 | $0.01 | $0.55 | — | $9.28 |
| 2023 | $3.35 | $0.04 | $0.01 | $0.22 | — | $9.47 |
| 2024 | $3.42 | −$0.33 | $0.01 | −$0.28 | — | $9.24 |
| 2025 | $3.67 | −$3.74 | $0.02 | −$1.87 | — | $5.54 |